Ocular light therapy arrangement and method for treating neurological disorders
AssigneeNorb Lighting, LLC.
InventorDavid S. MacKenzie
Life of this patent
Estimating the term…
Abstract
An ocular light therapy arrangement for treating a user having a neurologic disorder includes a light emitting device the emits a light having a flicker rate of less than or equal to about 2 Hz and/or greater than or equal to about 85,000 Hz at a wavelength of within a first range of from about 500 nm to about 565 nm, wherein the light is effective to reduce neurologic disorder symptoms by reducing stimulation of the user's retina and brain cortex.
Claims21
An ocular light therapy arrangement for treating a user having a neurologic disorder, comprising:
- a light emitting device that emits a light having a flicker rate of less than or equal to about 2 Hz and/or greater than or equal to about 85,000 Hz only at a first wavelength of within a first range of from about 500 nm to about 565 nm and at a second wavelength of within a second range of from about 800 nm to about 1 mm, such that the light has a targeted perception of flicker to mimic natural light through a canopy of foliage and is effective to reduce neurologic disorder symptoms by reducing stimulation of the user's retina and brain cortex, wherein the light has less than or equal to about 2.5% flicker within the first wavelength range of within the first range of from about 500 nm to about 565 nm.
A method for treating a neurological disorder of a user with an ocular light therapy arrangement, comprising:
- providing a light emitting device;
- actuating the light emitting device such that the light emitting device produces a light having a flicker rate of less than or equal to about 2 Hz and/or greater than or equal to about 85,000 Hz only at a first wavelength of within a first range of from about 500 nm to about 565 nm and at a second wavelength of within a second wavelength range of from about 800 nm to about 1 mm, wherein the light has less than or equal to about 2.5% flicker within the first wavelength range of within the first range of from about 500 nm to about 565 nm, such that the light has a targeted perception of flicker to mimic natural light through a canopy of foliage;
- and
- positioning the light emitting device such that the light emitted from the light emitting device illuminates a space occupied by the user, wherein the light is effective to reduce neurologic disorder symptoms by reducing stimulation of the user's retina and brain cortex.
An ocular light therapy arrangement for treating a user having a neurologic disorder, comprising:
- a light emitting device that emits a light having a flicker index of less than or equal to about 1.0 at a first wavelength of within a first range of from about 500 nm to about 565 nm and at a second wavelength of within a second range of from about 800 nm to about 1 mm, such that the light has a targeted perception of flicker to mimic natural light through a canopy of foliage and is effective to reduce neurologic disorder symptoms by reducing stimulation of the user's retina and brain cortex, wherein the light has less than or equal to about 2.5% flicker within the first wavelength range of within the first range of from about 500 nm to about 565 nm.
Dependencies are inferred from the claim text.